Saturday 17 October 2026 Export ANIK’s income statement to Excel — free account

Anika Therapeutics Inc.

ANIK Healthcare Drug Manufacturers Specialty & Generic

Anika Therapeutics Inc.’s revenue for fiscal 2025 (year ended December 2025) was $112.8 million, down 5.91% from fiscal 2024. In the quarter to June 2026, revenue grew 15.6%, EPS grew 189.3% and free cash flow grew 61.6%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

19.98 0.71 −3.43%

Follow ANIK

Alert me

Market cap: $276.9M
P/E: 0.0×
Fwd P/E: −20.0×
Dividend yield: —
F-score: 6/9
Altman Z: 3.13
Beneish M: −2.84
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
Piotroski F-Score Full definition →	7	6	6	6	+8 more TTM periods Free account
ROE Full definition →	(2.66%)	(7.84%)	(7.32%)	(20.23%)
ROA Full definition →	(2.04%)	(5.98%)	(5.54%)	(15.70%)
ROIC Full definition →	(3.24%)	(8.25%)	(8.03%)	(8.73%)
Return on Tangible Assets Full definition →	(3.23%)	(9.85%)	(8.93%)	(26.82%)
Average Days of Receivables Full definition →	87.92	80.90	76.64	71.79
Free Cash Flow per Share Full definition →	0.04	(0.21)	0.35	0.09
Free Cash Flow Full definition →	0.56	(2.86)	4.96	1.25
Capital Expenditures Full definition →	(5.41)	(9.33)	(6.23)	(6.88)
Other line items
Cash ROIC Full definition →	0.32%	(1.63%)	2.47%	0.61%
Accounts Receivable Turnover Full definition →	4.55	4.87	4.77	4.46
Accounts Payable Turnover Full definition →	8.29	8.29	8.41	8.85
Inventory Turnover Full definition →	2.01	2.18	2.30	1.83
Average Days of Payables Full definition →	49.86	48.06	44.99	33.83
Days of Inventory on Hand Full definition →	228.39	173.16	139.91	116.42
Tax Rate Full definition →	0.07	0.08	0.07	0.42
Research and Development Expense of Revenue Full definition →	22.75%	22.73%	22.84%	22.89%
Selling, General and Administrative Expense of Revenue Full definition →	43.66%	46.41%	43.51%	42.84%
Share Based Compensation of Revenue Full definition →	10.90%	11.92%	8.94%	8.76%
Operating CF/Net income Full definition →	(1.58)	(0.58)	(1.03)	(0.25)
Depreciation/Fixed assets Full definition →	0.14	0.14	0.14	0.14
Capex/Depreciation Full definition →	(0.96)	(1.68)	(1.09)	(1.23)
Revenue per Share Full definition →	9.05	8.59	7.87	7.82
Operating CF per Share Full definition →	0.45	0.48	0.78	0.56
Capex per Share Full definition →	(0.41)	(0.69)	(0.43)	(0.48)
Capex to Sales Full definition →	0.04	0.08	0.06	0.06

Show all line items

Columns are period end dates

Stockrow Weekly